Carterra (Biotechnology, Platforms) — Funding, Investors & Signals 2026

Carterra

High-throughput discovery and characterization technology

Founded 2005

Salt Lake City, United States 78 employees Series Unknown Total: $38.07M Biotechnology, Platforms

Carterra is a privately held biotechnology company based in the United States, founded in 2005. The company's slogan, "High-throughput discovery and characterization technology," aligns with its focus on accelerating and improving the discovery of novel therapeutic candidates. The recent $8.09M Venture Round investment on 14 December 2020 from Ballast Point Ventures, Telegraph Hill Partners, and PerkinElmer signifies confidence from notable investors in Carterra's innovative technologies. Carterra's flagship product, the LSA® instrument, is designed to deliver up to 100 times the throughput of existing platforms in 10% of the time while using only 1% of the sample required by other systems. This breakthrough is achieved through a combination of patented microfluidics technology with real-time high-throughput Surface Plasmon Resonance (HT-SPR) and industry-leading data analysis and visualization software. The company's new LSA-XT with enhanced optics promises additional applications in biotherapeutic discovery and characterization. With Customer Experience Centers in San Francisco, Salt Lake City, Boston, Manchester, England, and Munich, Germany, Carterra is strategically positioned to cater to its global clientele. Furthermore, its products are available in the Asia-Pacific and Oceania regions through exclusive distributor Revvity. Carterra's focus on high-throughput technologies, backed by recent investments and a strong global presence, positions the company as a key player in revolutionizing mAb screening and advancing biotherapeutic discovery and characterization. For additional information, visit www.carterra-bio.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	••••••	3	•••• ••••	14 Dec 2020
Venture Round	••••••	2		14 Jan 2020
Venture Round	••••••	1		17 Jan 2018
Venture Round	••••••	1	•••• ••••	18 Aug 2016
Venture Round	••••••	1	•••• ••••	01 Jul 2014

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

••••••

•••• ••••

14 Dec 2020

Venture Round

••••••

14 Jan 2020

Venture Round

••••••

17 Jan 2018

Venture Round

••••••

•••• ••••

18 Aug 2016

Venture Round

••••••

•••• ••••

01 Jul 2014

FAQ About Carterra

High-throughput discovery and characterization technology

Carterra was founded in 2005.

Carterra is headquartered in Salt Lake City, United States.

Carterra operates in the following industries: Biotechnology, Platforms.

Carterra has approximately 78 employees.

Carterra has completed 8 funding rounds, raising a total of $38.07M. The latest funding stage is Series Unknown.

Top alternatives and competitors to Carterra include Terray Therapeutics, Viron, Plexium, Silicon Kinetics, Materials and Systems Research, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Carterra and Terray Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Carterra

General Information

Track Carterra

Discover More

About Carterra

Funding Rounds & Investors (8)

Carterra Alternatives & Competitors

FAQ About Carterra

Don't just browse. Track.